Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 2

2860 - Prognostic value of metabolic response assessed by 18FDG-PET after induction chemotherapy and after chemoradiotherapy (CRT) in localized esophageal squamous cell carcinoma (ESCC) patients (pts) receiving definite CRT (dCRT)


29 Sep 2019


Poster Display session 2


Tumour Site

Oesophageal Cancer


Yeonghak Bang


Annals of Oncology (2019) 30 (suppl_5): v253-v324. 10.1093/annonc/mdz247


Y. Bang1, H. Jeong1, H. Im2, S.R. Park2

Author affiliations

  • 1 Department Of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 138-931 - Seoul/KR
  • 2 Department Of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 138-931 - Seoul/KR


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2860


Although, previous studies reported that metabolic response (MR) assessed by post-CRT 18FDG-PET was associated with survival outcomes in ESCC treated with dCRT, there are few data on the prognostic value of each metabolic response category after induction chemotherapy prior to dCRT and after completion of dCRT.


In this retrospective study, we evaluated prognostic value of MR after completion of induction chemotherapy and after completion of dCRT in 382 localized ESCC pts receiving induction chemotherapy followed by dCRT from January 2012 to February 2018 at Asan Medical Center in Korea. MR was assessed by EORTC criteria.


MR after induction chemotherapy was significantly associated with progression-free survival (PFS) and overall survival (OS). MR after dCRT was also significantly associated with PFS and OS. MR after either induction chemotherapy or dCRT remained significant after adjusting for other prognostic factors such as clinical TNM stage, sex, and ECOG performance status. Whereas pts achieving mCR/mPR or mPD after either induction chemotherapy or dCRT had good prognosis or poor prognosis, respectively, the prognostic value of mSD was different between post-induction chemotherapy and post-dCRT; it was similar to that of mPR after induction chemotherapy, but it was similar to that of mPD after dCRT. Poorer MR to induction chemotherapy could predict the lack of MR after dCRT; the proportion of mSD/mPD after dCRT was 7.7% in pts with post-induction mCR vs. 16.0% in pts with vs. 40.0% in pts with post-induction mSD vs. 100% in pts with post-induction mPD (p = 0.001).Table:


Post induction chemotherapyPost-dCRT
metabolic responseNHR for PFS (95% CI)P-valueHR for OS (95% CI)P-valueNHR for PFS (95% CI)P-valueHR for OS (95% CI)P-value
mPR1063.348 (1.221-9.181)0.0192.498 (1.008 - 6.192)0.0481642.182 (1.646-2.892)0.0002.224 (1.694-2.919)0.000
mSD106.008 (1.179-20.150)0.0043.640 (1.186-11.171)0.024711.251 (5.088-24.878)0.0009.659 (4.393-21.236)0.000
mPD259.209 (9.430-371.767)0.00014.495 (2.676-78.503)0.0023921.768 (14.020-33.797)0.00010.592 (7.016-15.989)0.000
diffuse esophagitis31.729 (0.193-15.482)0.6241.103 (0.129-9.453)0.929221.169 (0.651-2.098)0.6011.482 (0.856-2.566)0.160


MR after induction chemotherapy and after CRT had independent prognostic value with different prognostication between each other in ESCC pts receiving induction chemotherapy followed by dCRT.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.